Caspase-6 Undergoes a Distinct Helix-Strand Interconversion upon Substrate Binding.
Caspase-6 Undergoes a Distinct Helix-Strand Interconversion upon Substrate Binding.
复制标题
DOI:
10.1074/jbc.m116.773499
复制
发表时间:
2017-03-24
影响因子:
4.8
通讯作者:
Hardy, Jeanne A.
中科院分区:
文献类型:
--
作者:
Dagbay, Kevin B.;Bolik-Coulon, Nicolas;Hardy, Jeanne A.
Caspases are cysteine aspartate proteases that are major players in key cellular processes, including apoptosis and inflammation. Specifically, caspase-6 has also been implicated in playing a unique and critical role in neurodegeneration; however, structural similarities between caspase-6 and other caspase active sites have hampered precise targeting of caspase-6. All caspases can exist in a canonical conformation, in which the substrate binds atop a beta-strand platform in the 130' s region. This caspase-6 region can also adopt a helical conformation that has not been seen in any other caspases. Understanding the dynamics and interconversion between the helical and strand conformations in caspase-6 is critical to fully assess its unique function and regulation. Here, hydrogen/deuterium exchange mass spec-trometry indicated that caspase-6 is inherently and dramatically more conformationally dynamic than closely related caspase-7. In contrast to caspase-7, which rests constitutively in the strand conformation before and after substrate binding, the hydrogen/deuterium exchange data in the L2 ' and 130' s regions suggested that before substrate binding, caspase-6 exists in a dynamic equilibrium between the helix and strand conformations. Caspase-6 transitions exclusively to the canonical strand conformation only upon substrate binding. Glu-135, which showed noticeably different calculated pK(a) values in the helix and strand conformations, appears to play a key role in the interconversion between the helix and strand conformations. Because caspase-6 has roles in several neurodegenerative diseases, exploiting the unique structural features and conformational changes identified here may provide new avenues for regulating specific caspase-6 functions for therapeutic purposes.